Different antibiotic protocols in the treatment of severe chronic periodontitis: A 1‐year randomized trial
- 26 July 2017
- journal article
- research article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 44 (8) , 822-832
Abstract
Aim: To evaluate the clinical effects of different dosages of metronidazole (MTZ) and durations of MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (GChP).Material and Methods: Subjects with severe GChP were randomly assigned to receive scaling and root planing (SRP)‐only, or combined with 250 or 400 mg of MTZ + AMX (500 mg) thrice a day (TID), for 7 or 14 days. Subjects were monitored for 1 year.Results: One hundred and nine subjects were enrolled. At 1 year, 61.9% and 63.6% of the subjects receiving AMX + 250 or 400 mg of MTZ for 14 days, respectively, reached the clinical endpoint for treatment (≤4 sites with probing depth ≥5 mm), against 31.8% of those taking 250 or 400 mg of MTZ for 7 days (p < .05) and 13.6% of those receiving SRP‐only (p < .05). Fourteen days of MTZ + AMX was the only significant predictor of subjects reaching the clinical endpoint at 1 year (OR, 5.26; 95% CI, 2.3–12.1, p = .0000). The frequency of adverse events did not differ among treatment groups (p > .05).Conclusion: The adjunctive use of 400 or 250 mg of MTZ plus 500 mg of AMX/TID/14 days offers statistically significant and clinically relevant benefits over those achieved with SRP alone in the treatment of severe GChP. The added benefits of the 7‐days regimen in this population were less evident. (ClinicalTrials.gov NCT02735395).Keywords
Funding Information
- São Paulo Research Foundation (FAPESP, Brazil). (2009/17677-8)
This publication has 42 references indexed in Scilit:
- Metronidazole alone or with amoxicillin as adjuncts to non‐surgical treatment of chronic periodontitis: a 1‐year double‐blinded, placebo‐controlled, randomized clinical trialJournal of Clinical Periodontology, 2012
- Clinical relevance vs. statistical significance: Using neck outcomes in patients with temporomandibular disorders as an exampleManual Therapy, 2011
- Systemic Antimicrobials Adjunctive to a Repeated Mechanical and Antiseptic Therapy for Aggressive Periodontitis: A 6‐Month Randomized Controlled TrialJournal of Periodontology, 2011
- General Principles of Antimicrobial TherapyMayo Clinic Proceedings, 2011
- Efficacy of Amoxicillin and Metronidazole Combination for the Management of Generalized Aggressive PeriodontitisJournal of Periodontology, 2010
- Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapyJournal of Clinical Periodontology, 2009
- Full‐Mouth Ultrasonic Debridement Associated With Amoxicillin and Metronidazole in the Treatment of Severe Chronic PeriodontitisJournal of Periodontology, 2009
- Factorial Designs in Clinical Trials2008
- Simultaneous determination of metronidazole and spiramycin I in human plasma, saliva and gingival crevicular fluid by LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2005
- Development of a Classification System for Periodontal Diseases and ConditionsAnnals of Periodontology, 1999